Showing results (21-30 of 5,002) with videos related to
Sort By:
Pageof 501
The International Journal of Neuroscience|June 1, 1997
IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine monthsS A Brod, L D Nelson, M Khan, et al.Journal of the Neurological Sciences|March 13, 2012
Variable results after rituximab in neuromyelitis opticaJ W Lindsey, K M Meulmester, S A Brod, et al.Autoimmunity|January 1, 1996
Oral administration of type I interferon modulates the course of experimental allergic neuritisF J Vriesendorp, R E Flynn, M Khan, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2000
Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretionS A Brod, M Khan, L D Nelson, et al.Annals of Neurology|June 1, 1991
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pigS A Brod, A al-Sabbagh, R A Sobel, et al.Neurology|June 1, 1996
Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosisS A Brod, G D Marshall, E M Henninger, et al.Annals of Neurology|January 1, 1991
Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosisS J Lee, K W Wucherpfennig, S A Brod, et al.Neurology|September 12, 2001
Ingested IFN-alpha: results of a pilot study in relapsing-remitting MSS A Brod, J W Lindsey, F S Vriesendorp, et al.Annals of Neurology|April 1, 1995
Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosisS A Brod, M Khan, J Bright, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 19, 2002
Ingested IFN-alpha preserves residual beta cell function in type 1 diabetesS A Brod, M Atkinson, V R Lavis, et al.Pageof 501